238 related articles for article (PubMed ID: 8095456)
1. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D
Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
[TBL] [Abstract][Full Text] [Related]
2. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
Hirokawa M; Gray JD; Takahashi T; Horwitz DA
J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
[TBL] [Abstract][Full Text] [Related]
3. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
Costello R; Brailly H; Mallet F; Mawas C; Olive D
Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
[TBL] [Abstract][Full Text] [Related]
5. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
6. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
[TBL] [Abstract][Full Text] [Related]
7. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
Cerdan C; Martin Y; Courcoul M; Brailly H; Mawas C; Birg F; Olive D
J Immunol; 1992 Oct; 149(7):2255-61. PubMed ID: 1356123
[TBL] [Abstract][Full Text] [Related]
8. IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways.
Cerdan C; Martin Y; Brailly H; Courcoul M; Flavetta S; Costello R; Mawas C; Birg F; Olive D
J Immunol; 1991 Jan; 146(2):560-4. PubMed ID: 1670946
[TBL] [Abstract][Full Text] [Related]
9. Human atopen-specific types 1 and 2 T helper cell clones.
Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
[TBL] [Abstract][Full Text] [Related]
10. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
Conlon KC; Ochoa AC; Kopp WC; Ortaldo JR; Urba WJ; Longo DL; Young HA
J Immunol; 1992 Nov; 149(10):3278-89. PubMed ID: 1358968
[TBL] [Abstract][Full Text] [Related]
11. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation.
Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S
Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977
[TBL] [Abstract][Full Text] [Related]
12. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
[TBL] [Abstract][Full Text] [Related]
13. Contributions of the CD2 and CD28 T lymphocyte activation pathways to the regulation of the expression of the colony-stimulating factor (CSF-1) gene.
Cerdan C; Razanajaona D; Martin Y; Courcoul M; Pavon C; Mawas C; Olive D; Birg F
J Immunol; 1992 Jul; 149(2):373-9. PubMed ID: 1352526
[TBL] [Abstract][Full Text] [Related]
14. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
[TBL] [Abstract][Full Text] [Related]
15. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
16. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
Wasik MA; Morimoto C
J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
[TBL] [Abstract][Full Text] [Related]
18. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
Damle NK; Leytze G; Klussman K; Ledbetter JA
Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of cloned human T lymphocytes via the CD3 or CD28 molecules induces enhancement in vascular endothelial permeability to macromolecules with participation of type-1 and type-2 intercellular adhesion pathways.
Damle NK; Doyle LV
Eur J Immunol; 1990 Sep; 20(9):1995-2003. PubMed ID: 1698638
[TBL] [Abstract][Full Text] [Related]
20. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.
Levine BL; Bernstein WB; Connors M; Craighead N; Lindsten T; Thompson CB; June CH
J Immunol; 1997 Dec; 159(12):5921-30. PubMed ID: 9550389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
